A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival
Authors
Keywords
Gastric cancer, S-1, Docetaxel, Perioperative chemotherapy, <em class=EmphasisTypeItalic >CYP2A6</em> genotype
Journal
Gastric Cancer
Volume 19, Issue 2, Pages 586-596
Publisher
Springer Nature
Online
2015-04-07
DOI
10.1007/s10120-015-0490-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II Study of Docetaxel and S-1 (DS) as Neoadjuvant Chemotherapy for Clinical Stage III Resectable Gastric Cancer
- (2014) Eiji Oki et al. ANNALS OF SURGICAL ONCOLOGY
- Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis
- (2014) A. Tsuburaya et al. BRITISH JOURNAL OF SURGERY
- A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma
- (2013) Inkeun Park et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)
- (2013) Wasaburo Koizumi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010
- (2013) Kyu-Won Jung et al. Cancer Research and Treatment
- Proposal for a Multifactorial Prognostic Score That Accurately Classifies 3 Groups of Gastric Carcinoma Patients With Different Outcomes After Neoadjuvant Chemotherapy and Surgery
- (2012) Karen Becker et al. ANNALS OF SURGERY
- Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
- (2012) Yung-Jue Bang et al. LANCET
- Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy
- (2011) Kun Liu et al. ACTA RADIOLOGICA
- Molecular Imaging of Proliferation and Glucose Utilization: Utility for Monitoring Response and Prognosis after Neoadjuvant Therapy in Locally Advanced Gastric Cancer
- (2011) Katja Ott et al. ANNALS OF SURGICAL ONCOLOGY
- CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients
- (2011) S R Park et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
- (2011) Marc Ychou et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant chemotherapy with FOLFOX: Improved outcomes in Chinese patients with locally advanced gastric cancer
- (2011) Zi-Yu Li et al. JOURNAL OF SURGICAL ONCOLOGY
- Prognostic Value of Preoperative Clinical Staging Assessed by Computed Tomography in Resectable Gastric Cancer Patients
- (2010) Sook Ryun Park et al. ANNALS OF SURGERY
- A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy
- (2010) Hei-Cheul Jeung et al. CANCER
- Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
- (2010) Christoph Schuhmacher et al. JOURNAL OF CLINICAL ONCOLOGY
- [18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer
- (2010) D. Vallböhmer et al. JOURNAL OF SURGICAL ONCOLOGY
- Association ofCYP2A6polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer
- (2009) Sun-Young Kong et al. PHARMACOGENOMICS
- Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction
- (2008) M. Dank et al. ANNALS OF ONCOLOGY
- Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma
- (2008) S R Park et al. BRITISH JOURNAL OF CANCER
- Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer
- (2008) Sook Ryun Park et al. CANCER
- CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1
- (2008) Ken-ichi Fujita et al. CANCER SCIENCE
- Early Metabolic Response Evaluation by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Allows In vivo Testing of Chemosensitivity in Gastric Cancer: Long-term Results of a Prospective Study
- (2008) K. Ott et al. CLINICAL CANCER RESEARCH
- The CYP2A6*4 Allele Is Determinant of S-1 Pharmacokinetics in Japanese Patients With Non-small-cell Lung Cancer
- (2008) Y Kaida et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now